Skip to main content
SpringerLink
Log in

Norwegian participation in EU drug procedures

  • News
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliography

  • St.prp. 93; (White paper, Norwegian Government): Agreement on the approval of the Commission’s decision no. 74/1999, 28 May 1999, change in the EEA agreement protocol 37 and attachment II Closer connection EU co operation in the field of medicine.

  • Transition periods in connection with the extension of the EEA-agreement (1999), 26 May. Norwegian Medicines Control Authority.

  • Medicines Regulations (1999), 22 December, Ministry of Health and Social Affairs,Norway.

  • New Medicines Regulations (2000), 28 January, Norwegian Medicines Control Authority.

  • The Norwegian Drug Bulletin (1999), 22; 4, 125–172. Published by the Norwegian Medicines Control Authority.

  • News from Nordic Drug Council (1999), 4; 6–7. Published by the Norwegian Drug Council.

  • Guidance document for industry, with regard to the extension of the centralised procedure to Norway and Iceland. EMEA, London 16 March 2000.

Download references

Author information

Authors and Affiliations

  1. Norway

    Kisten Hjelle

Authors
  1. Kisten Hjelle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hjelle, K. Norwegian participation in EU drug procedures. International Journal of Pharmaceutical Medicine 14, 125–126 (2000). https://doi.org/10.1097/00124363-200006000-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1097/00124363-200006000-00003

Search

Navigation